ProShare Advisors’s aTyr Pharma ATYR Stock Holding History

ProShare Advisors’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.8K	Sell	13,905 -3,619	-21%	-$3.06K	﹤0.01%	1854
2025 Q4	$13.7K	Buy	17,524 +2,651	+18%	+$2.18K	﹤0.01%	2029
2025 Q3	$10.7K	Sell	14,873 -2,964	-17%	-$13.4K	﹤0.01%	2004
2025 Q2	$90.4K	Buy	+17,837	New	+$70.2K	﹤0.01%	1895
2016 Q4	–	Sell	-1,068	Closed	-$48K	–	1754
2016 Q3	$48K	Sell	1,068 -191	-15%	-$8.25K	﹤0.01%	1441
2016 Q2	$49K	Sell	1,259 -35	-3%	-$1.63K	﹤0.01%	1553
2016 Q1	$71K	Sell	1,294 -127	-9%	-$9.65K	﹤0.01%	1540
2015 Q4	$196K	Buy	+1,421	New	+$202K	﹤0.01%	1550

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ProShare Advisors's ATYR Position: Q1 2026 in Review

ProShare Advisors reduced its aTyr Pharma (ATYR) stake by 21% in Q1 2026, selling an estimated $3.06K and leaving 13,905 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1854.

ProShare Advisors first reported a position in ATYR in Q4 2015 and has held it in 8 quarters since. The position peaked at $196K in Q4 2015. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

ProShare Advisors held 13,905 shares of aTyr Pharma worth $10.8K as of Q1 2026.
ProShare Advisors sold 3,619 aTyr Pharma shares in Q1 2026, an estimated $3.06K.
aTyr Pharma made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1854 holding.
ProShare Advisors first reported a position in aTyr Pharma in Q4 2015 and has held it in 8 quarters since.
ProShare Advisors's aTyr Pharma position peaked at $196K in Q4 2015.
111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.